HUTCHMED (China) (HCM) Income from Continuing Operations (2015 - 2021)
HUTCHMED (China) (HCM) posted quarterly Income from Continuing Operations of 212018000.0 for Q4 2021, down 247.75% quarter-over-quarter from 60968000.0 in Q1 2021.
HUTCHMED (China) (HCM) Income from Continuing Operations (2015 - 2021) Analysis & Trends
HUTCHMED (China) (HCM) has reported Income from Continuing Operations for 6 consecutive years, with 212018000.0 the latest figure, recorded in Q4 2021.
- In Q4 2021, Income from Continuing Operations changed N/A year-over-year to 212018000.0; the TTM figure through Dec 2021 stood at 347534000.0 (changed N/A YoY), while the FY2025 annual figure was 64438434.71, up 8162.83% from the prior year.
- Income from Continuing Operations retreated to 212018000.0 in Q4 2021 per HCM's latest filing, from 60968000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 70120000.0 in Q2 2018 and bottomed at 212018000.0 in Q4 2021.
- Historically, Income from Continuing Operations has averaged 33556166.67 across 4 years, with a median of 32258500.0 in 2019.
- On a YoY basis, Income from Continuing Operations climbed as much as 250.63% in 2019 and fell as far as 367.87% in 2019.
- HUTCHMED (China)'s Income from Continuing Operations stood at 22093000.0 in 2018, then plunged by 270.87% to 37750000.0 in 2019, then declined by 17.28% to 44273000.0 in 2020, then slumped by 378.89% to 212018000.0 in 2021.
- Business Quant data shows HCM's Income from Continuing Operations at 212018000.0 in Q4 2021, 60968000.0 in Q1 2021, and 44273000.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 1.33 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | HUTCHMED (China) | 2.16 Bn | 2.16 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -212.02 Mn |
| Mar 31, 2021 | -60.97 Mn |
| Jun 30, 2020 | -44.27 Mn |
| Mar 31, 2020 | -30.28 Mn |
| Dec 31, 2019 | -37.75 Mn |
| Sep 30, 2019 | -34.24 Mn |
| Jun 30, 2019 | -99.44 Mn |
| Mar 31, 2019 | 33.60 Mn |
| Dec 31, 2018 | 22.09 Mn |
| Sep 30, 2018 | 12.78 Mn |
| Jun 30, 2018 | 70.12 Mn |
| Mar 31, 2018 | -22.31 Mn |
| Jun 30, 2016 | 29.56 Mn |
| Jun 30, 2015 | 23.49 Mn |